Linking the <i>FTO</i> obesity rs1421085 variant circuitry to cellular, metabolic, and organismal phenotypes in vivo.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34290091.
- Also identified by DOI 10.1126/sciadv.abg0108 and PMC identifier 8294759.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Variants in FTO have the strongest association with obesity; however, it is still unclear how those noncoding variants mechanistically affect whole-body physiology. We engineered a deletion of the rs1421085 conserved cis-regulatory module (CRM) in mice and confirmed in vivo that the CRM modulates <i>Irx3</i> and <i>Irx5</i> gene expression and mitochondrial function in adipocytes. The CRM affects molecular and cellular phenotypes in an adipose depot-dependent manner and affects organismal phenotypes that are relevant for obesity, including decreased high-fat diet-induced weight gain, decreased whole-body fat mass, and decreased skin fat thickness. Last, we connected the CRM to a genetically determined effect on steroid patterns in males that was dependent on nutritional challenge and conserved across mice and humans. Together, our data establish cross-species conservation of the rs1421085 regulatory circuitry at the molecular, cellular, metabolic, and organismal level, revealing previously unknown contextual dependence of the variant's action.
Medical subject headings
- Alpha-Ketoglutarate-Dependent Dioxygenase FTO
- Obesity